4.7 Article

The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry

Related references

Note: Only part of the references are listed.
Article Oncology

Definitive pelvic radiation therapy improves survival in stage IVB neuroendocrine cervical carcinoma: A NeCTuR study

Gloria Salvo et al.

Summary: This study evaluated the survival impact of adding definitive pelvic radiation therapy (RT) to chemotherapy in patients with stage IVB neuroendocrine cervical carcinoma (NECC). The results showed that adding RT to chemotherapy improved the progression-free survival (PFS) and overall survival (OS) of patients compared to chemotherapy alone. Therefore, pelvic RT may have a significant impact on the survival of patients with stage IVB NECC.

GYNECOLOGIC ONCOLOGY (2022)

Article Respiratory System

Stage I and II Small-Cell Lung Cancer-New Challenge for Surgery

Fabian Doerr et al.

Summary: This article presents a meta-analysis on the mean-survival of patients with small-cell lung cancer (SCLC) in stage I and II who underwent surgery compared to those who did not. The results show a significant survival benefit after surgery in both stage I and II SCLC.
Review Surgery

Redefining the role of surgery in early small-cell lung cancer

Fabian Doerr et al.

Summary: Based on the conducted meta-analysis, surgery has shown significant survival benefits in the treatment of both stage I and stage II SCLC. Therefore, guideline recommendations may need to be reassessed.

LANGENBECKS ARCHIVES OF SURGERY (2022)

Review Biochemistry & Molecular Biology

Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?

Margherita Turinetto et al.

Summary: The prognosis of invasive cervical cancer remains poor and the standard treatment approach has not made significant progress. However, recent research on the interaction between the disease and the immune system has opened up new possibilities for immune therapy. Immunotherapy strategies such as immune checkpoint inhibitors, tumor infiltrating lymphocytes, and antibody drug conjugates have shown promising results in clinical trials. The development of predictive biomarkers is also being explored to guide treatment decisions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Obstetrics & Gynecology

Optimal treatment strategies for small cell carcinoma of the uterine cervix: A retrospective multi-center study (KROG 19-03)

Won Kyung Cho et al.

Summary: This multi-institutional study suggests that definitive radiotherapy is a reasonable local treatment option for small cell carcinoma of the cervix, especially for advanced cases. There was no significant difference in progression-free survival and overall survival between patients who underwent primary surgery and those who received primary radiotherapy.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Obstetrics & Gynecology

Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix

Thomas A. Paterniti et al.

Summary: Small cell neuroendocrine carcinoma of the cervix is a rare and aggressive tumor, with poor survival rates. In a case study, a 52-year-old woman with recurrent disease achieved a complete and durable response after treatment with a combination of nivolumab and ipilimumab, suggesting that this treatment option may be promising for this type of cancer.

OBSTETRICS AND GYNECOLOGY (2021)

Article Oncology

Small cell carcinoma as an independent prognostic factor for cervical cancer patients: a population-based analysis

Wang Miao et al.

Summary: This study compared cervical small cell carcinoma (SmCC) with squamous cell carcinoma (SCC) in patient characteristics and survival outcomes, finding that cervical SmCC patients generally had larger tumors, more advanced disease, and more instances of lymph node or distant metastasis, with SmCC being an independent poor prognostic factor in cervical cancer patients.

FUTURE ONCOLOGY (2021)

Review Oncology

Immunotherapy in cervix cancer

Laura Attademo et al.

CANCER TREATMENT REVIEWS (2020)

Article Obstetrics & Gynecology

Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy

Xiong Li et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)

Article Oncology

Prognostic Factors for Small Cell Neuroendocrine Carcinoma of the Uterine Cervix An Institutional Experience

Suthida Intaraphet et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)

Article Obstetrics & Gynecology

Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients

Joshua G. Cohen et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)

Article Oncology

Neuroendocrine tumors of the gastrointestinal tract - A decade of experience at the Princess Margaret Hospital

Jeff Rothenstein et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)

Review Oncology

Small cell carcinoma of the female genital tract

Sara Crowder et al.

SEMINARS IN ONCOLOGY (2007)

Article Oncology

Cervical cancer incidence and survival in Korea: 1993-2002

H. H. Chung et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)